Key result
Pregnancy with pulmonary hypertension carries maternal mortality peaking at ~50% in idiopathic cases.
Why the study?
Despite improvements in monitoring and targeted drugs, maternal mortality in women with pulmonary hypertension remains high, prompting a description of maternal-foetal outcomes.
Observational (n=154)
No
p-value: p=<0.001
Pregnancy in women with pulmonary hypertension carries significant maternal and fetal risks, with idiopathic PAH associated with particularly high maternal mortality (50%).
High maternal mortality in pulmonary hypertension, especially idiopathic PAH, supports pre-pregnancy counseling; larger prospective studies needed to guide management.
BACKGROUND: In recent years, with the development of monitoring conditions and the application of pulmonary vascular-targeted drugs, pregnancy outcomes in women with pulmonary hypertension (PH) have improved, but the maternal mortality rate is still high. The purpose of this study was to describe the maternal-foetal outcomes in pregnant women with PH. METHODS: The clinical data of 154 pregnant women with PH who were admitted to the Third Affiliated Hospital of Guangzhou Medical University from January 2011 to December 2020 were collected and descriptively analysed. RESULTS: Among the 154 pregnant women with PH, 6 (3.9%) had idiopathic pulmonary arterial hypertension (iPAH), 41 (26.6%) had pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD-PAH), 45 (29.2%) had PAH related to other diseases (oPAH), and 62 (40.3%) had PH related to left heart disease (LHD-PH). The systolic pulmonary artery pressure (sPAP) was 36-49 mmHg in 53.2% of the patients, 50-69 mmHg in 22.1% of the patients and ≥ 70 mmHg in 24.7% of the patients. Five (3.2%) pregnant women died within 1 week after delivery; iPAH patients had the highest mortality rate (3/6, 50%). Fifty-four patients (35.1%) were admitted to the intensive care unit (ICU), and the incidence of heart failure during pregnancy was 14.9%. A total of 70.1% of the patients underwent caesarean section; 42.9% had premature infants; 28.6% had low-birth-weight (LBW) infants; 13.0% had very-low-birth-weight (VLBW) infants; 3.2% had extremely-low-birth-weight (ELBW) infants; 61% had small for gestational age (SGA) infants; and 1.9% experienced neonatal mortality. CONCLUSION: There were significant differences in the maternal-foetal outcomes in the iPAH, CHD-PAH, oPAH and LHD-PH groups. Maternal mortality was highest in the iPAH group; therefore, iPAH patients should be advised to prevent pregnancy. Standardized and multidiscipline-assisted maternal management is the key to improving maternal-foetal outcomes.
No takes yet. Share an insight, caveat, or question.
Lv et al. (2023) conducted an observational in Pulmonary hypertension in pregnancy (n=154). Among pregnant women with pulmonary hypertension, overall maternal mortality was 3.2%, with the highest mortality rate of 50% observed in patients with idiopathic pulmonary arterial hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: